NDC Product
Human Prescription DrugEverolimus NDC 60219-2279
- Generic Name
- Everolimus
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Marketing
- ANDA
Active Listing
This profile provides standardized clinical and technical data for Everolimus, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9HW64Q8G6G.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 159351-69-6 and the RxNorm Concept ID (RxCUI) 141704. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
C53H83NO14 HKVAMNSJSFKALM-GKUWKFKPSA-N This section provides a complete list of nomenclature and identifier mappings for Everolimus. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: